AANA19 Knee Access Pass-Five Questions for Andreas Gomoll, MD-Dr. Nicholas A. Sgaglione, M.D.

Five Questions for Andreas Gomoll, MD-Dr. Nicholas A. Sgaglione, M.D.

Video Transcription

Video Summary

Andrea Scamal discusses cartilage defect treatments, emphasizing not treating asymptomatic lesions unless risk factors exist. He distinguishes between minor defects that may not need intervention and large, symptomatic ones requiring treatment. He prefers osteochondral allografts for deep bone defects and highlights osteotomy as a powerful tool for malalignment, often prioritizing cartilage over meniscus repair. Chondroplasty suffices for mechanical symptoms without significant pain. Insurance approvals can hinder newer procedures but osteochondral allografts and ACI are commonly covered. Microfracture is considered outdated, favoring drilling instead. Scamal stresses individualized patient care, regional centers of excellence, and foresees advances in minimally invasive and cell-based therapies for cartilage repair.

Keywords

cartilage defect treatments

osteochondral allografts

osteotomy for malalignment

chondroplasty

cell-based therapies